Reaching consensus amongst international experts on the use of high importance-rated antimicrobials in animals – a Delphi study
Anna Sri,
Kirsten E. Bailey,
Ri Scarborough,
James R. Gilkerson,
Karin Thursky,
Glenn F. Browning,
Laura Y. Hardefeldt
Affiliations
Anna Sri
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia; Corresponding author at: Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia.
Kirsten E. Bailey
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
Ri Scarborough
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
James R. Gilkerson
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
Karin Thursky
National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
Glenn F. Browning
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
Laura Y. Hardefeldt
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Parkville, VIC 3010, Australia; National Centre for Antimicrobial Stewardship, Department of Infectious Diseases Melbourne Medical School and Melbourne Veterinary School, University of Melbourne, VIC 3010, Australia
In Australia, antimicrobials are given an importance rating by the Australian Strategic and Technical Advisory Group on antimicrobial resistance. High importance antimicrobials are those essential for the treatment or prevention of infections in humans, where there are few or no treatment alternatives. In this study we consulted with experts from across human and animal health using the Delphi consensus-building process to establish the circumstances under which antimicrobials with high importance to human health could be used in animals in Australia. We used three rounds of online surveys. Group responses were provided to participants in each subsequent round to facilitate convergence of opinion. Consensus was defined as 80 % or more of respondents selecting the same option for a question. By the end of the third round, consensus was achieved on eight items. This included the use of high importance antimicrobials being appropriate if culture and sensitivity testing indicated the organism was resistant to low- and medium-rated antimicrobials that could be used to treat the case. If any high-importance antimicrobials are prescribed for animals there was also agreement that a clear indication for this use and justification for antimicrobial choice must be recorded in the medical history, along with the dose rate, route of administration, the duration and the time point for review of the condition and associated antimicrobial therapy.Appropriateness of use of high importance antimicrobials in critically ill animals where culture and sensitivity results are not available is still undefined. Further work is also required to establish which particular organisation should be notified of the use of high importance antimicrobials not registered for use in animals. The Delphi process was valuable in facilitating consensus amongst international experts from a broad range of health backgrounds and experience.
